The Advertising Standards Council of India (ASCI) is not a court. It cannot legally prosecute. But ignoring ASCI guidelines for UGC ads in India in 2026 is one of the fastest ways to get your Meta ad account restricted, your D2C brand publicly named in their monthly violation reports, and (in regulated categories like fintech and ayurveda) trigger separate regulator action that has real teeth.
This is the complete compliance guide we use with our 100+ Indian D2C clients in 2026, broken down by category.
The two ASCI documents that matter
- ASCI Code for Self-Regulation in Advertising (general). The umbrella code covering all advertising including UGC.
- ASCI Influencer Guidelines 2024 (updated for 2026). The specific guide for paid creator content — UGC and influencer marketing fall here.
Both apply to every UGC ad an Indian D2C brand runs. The brand is the legal liable party — not just the creator.
The disclosure rule (non-negotiable)
Every paid creator video MUST disclose its paid-partnership nature. This is not optional and applies regardless of compensation type (cash, gift, discount, exclusive product access).
Acceptable disclosure formats:
- Instagram's "Paid Partnership" tag (preferred — Instagram-native)
- "#ad" or "#sponsored" hashtag in first 3 lines of caption
- "Advertisement" or "Sponsored by [brand]" verbally in the first 5 seconds
- Visible on-screen "Paid Partnership" text in the first 3 seconds
NOT acceptable:
- "Partnership", "Collab", "Affiliate" alone (without #ad clarification)
- Disclosure buried at end of caption ("Read more" tap-to-expand)
- Disclosure only in story highlights but not in the Reel/post itself
- "#collab" or "#brandlove" alone without paid-status clarification
The bar: a typical viewer, glancing at the content, should know within 3 seconds that this is paid advertising.
Category-specific prohibited claims
Beauty & Skincare
Subject to ASCI + Drugs and Cosmetics Act, 1940 + Drugs and Magic Remedies Act, 1954.
- NO claims of treating/curing acne, eczema, psoriasis, melasma, vitiligo (any "disease" condition)
- NO "instant" / "permanent" / "guaranteed" results language
- Before/after images require: timeframe disclosure, "Results May Vary" disclaimer, no over-touched edits
- No suggesting product alone is responsible for skin transformation (must show realistic context)
Fintech, Lending, Investment Products
Subject to ASCI + RBI Master Directions + SEBI advertising rules + IRDAI for insurance.
- NO "guaranteed returns" language on any investment product (even mutual fund SIPs)
- NO past-returns-imply-future-returns claims without "past performance not indicative" disclaimer
- NO "risk-free" or "100% safe" claims on equity/debt products
- Lending/credit products must disclose APR/IRR alongside any "₹ per month" or "easy EMI" claim
- "Tax-free" claims require category accuracy (ELSS yes, regular MF no)
Food, Beverage, FMCG
Subject to ASCI + FSSAI labeling regulations + Food Safety and Standards Act, 2006.
- "Natural", "Organic", "Pure" claims require FSSAI registration matching
- "No preservatives" requires actual no-preservatives formulation (not just no specific ones)
- "Doctor-recommended" / "Dietitian-approved" needs actual professional endorsement on file
- Nutrition claims must match label panels — "high protein" requires meeting FSSAI threshold
- Children-targeted advertising has stricter rules under ASCI's Children's Code
Ayurveda, Supplements, Wellness
Subject to ASCI + AYUSH Ministry rules + Drugs and Magic Remedies Act.
- NO disease cure claims — "ashwagandha cures anxiety" is illegal advertising
- "Traditional use" framing is allowed: "Used in Ayurveda for stress" yes; "Cures stress" no
- Mandatory disclaimers on transformation visuals
- "Ayurvedic" claim requires AYUSH registration of the product
- No promotion of supplements as replacements for food / medical treatment
Real Estate
Subject to ASCI + RERA Act, 2016.
- Every property promotion must include RERA registration number where applicable
- NO guaranteed appreciation / "doubles in X years" claims
- NO possession-date guarantees on under-construction projects
- Renderings must clearly indicate "artist's impression" / "actual may vary"
Gaming & Real-Money Gaming
Subject to ASCI + MeitY Online Gaming Intermediary Rules 2023.
- "This game involves financial risk and may be addictive" disclaimer mandatory
- Age-gate disclosure required (18+)
- State-restriction disclosure for states where real-money gaming is banned (TN, AP, TG, MP, KA, OD, AS)
- NO testimonial-based promotion of real-money gaming wins
Real ASCI violation cases (2024-2026)
ASCI publishes monthly violation reports naming specific brands. Recent patterns:
- Beauty/skincare brands repeatedly cited for "instant fairness" / "removes melasma in 7 days" claims
- Crypto / Web3 platforms cited for missing disclaimers on speculative-investment promotion
- EdTech cited for guaranteed outcome language ("Crack JEE in 6 months")
- Weight-loss supplements cited for transformation videos without disclaimers
- Influencer-led posts cited for missing #ad disclosure across multiple categories
The downstream effect: ASCI public naming → Meta and Instagram tighten ad review for that brand handle → ad account restrictions → revenue impact.
Our compliance checklist (every UGC video we produce)
Before any UGC video goes to shoot, we run this checklist:
- Script reviewed against ASCI 2024 by category specialist
- Disclosure format chosen and integrated (paid partnership tag + #ad)
- No prohibited language (no "guaranteed", "instant", "cure", "100% safe", "permanent")
- Required disclaimers added (Results May Vary / Risk Disclosure / RERA / AYUSH as needed)
- Before/after visuals include timeframe + disclaimer
- Category-specific regulator language verified (RBI/SEBI/FSSAI/AYUSH/MeitY/RERA)
- Final delivery review — disclosure visible in first 3 seconds of all variants
What happens if you skip compliance
Best case: ASCI sends a private notice asking you to modify or take down the ad. You comply, you continue.
Middle case: ASCI publishes you in their monthly violation report. Meta's ad-review algorithm flags your brand handle. Your ad accounts face higher rejection rates for 30-60 days.
Worst case: regulator-specific action — RBI freezes a fintech promotion, FSSAI issues a public notice, AYUSH demands product registration audit. Brand reputation damage is months to repair.
[FOUNDER ADD: an anonymised real example of a brand that got into ASCI trouble and what it cost them]
How we handle compliance for clients
Every UGC engagement with us includes category-specific compliance review at script stage. We've built domain expertise in:
- Beauty/skincare ASCI + Drugs & Cosmetics review
- Fintech RBI/SEBI/IRDAI script audit
- Food/FMCG FSSAI label compliance
- Ayurveda/wellness AYUSH compliance
- Real estate RERA disclosure
- Gaming MeitY 2023 compliance
- EdTech outcome-claim audit
This is built into our standard delivery — no extra cost on Starter / Growth / Scale plans.
Book a compliance-aware UGC strategy call →